Tafasitamab (Anti-CD19)
Product Specifications
CAS Number
1422527-84-1
Synonyms
XmAb5574; MOR00208; Tafasitamab-cxix
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Tafasitamab (Anti-CD19) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigen CD19. It is used in combination with allogeneic NK cell therapy in treatment of B-cell non-Hodgkin's lymphoma. MW:145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0065408 1.0 µg DNA
AKAP1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details NBP3-20217JF646 0.1 mL
Rabbit Polyclonal MERS-CoV Spike Protein Antibody [Janelia Fluor 646]
Sign In for Pricing
View Details TL708971V 500 µL Each
Map9 Rat shRNA Lentiviral Particle (Locus ID 310544)
Sign In for Pricing
View Details